Previously, we have shown that activation of MAPK pathfrom deleterious mutations in the dystrophin gene, with a complete loss of the protein product [1, 2].
Subsequently, the disease is manifested in severe striated muscle wasting and death in early adulthood phosphorylation/activity status was assessed in cardiac and skeletal muscle lysates collected from control mice and
. Dystrophin provides a structural base for the assembly of an integral membrane protein complex two murine dystrophic models, the mdx and mdx: MyoD Ϫ/Ϫ strains ( Figure 1 ). The selection of both the [4] . As such, dystrophin deficiency leads to an altered mechanical integrity of the myofiber and a mdx (murine genetic equivalent of DMD) and mdx: MyoD Ϫ/Ϫ strain provided a gradation in the dystrophic predisposition to contraction-induced damage [5] [6] [7] . However, the development of myofiber phenotype for these analyses (the loss of MyoD results in an inability to effectively repair damaged skeletal musdegeneration prior to an observed mechanical defect has been documented in various dystrophic cle; as such, the mdx:MyoD Ϫ/Ϫ strain displays a more pronounced dystrophy) [12] . Moreover, the cumulative models [8, 9] . Although activation of a detrimental signal transduction pathway has been suggested as damage observed in mdx:MyoD Ϫ/Ϫ skeletal muscle is also concurrent to a progressive cardiac dystrophy that is not a probable cause, a specific cellular cascade has yet to be defined. Here, it is shown that murine present in the mdx mouse [10] . Altered phosphorylation of the stress-activated MAPK JNK1 (p54 isoform) was models of DMD displayed a muscle-specific activation of JNK1. Independent activation of JNK1 evident in immunoprecipitated (IPed) lysates derived from dystrophic muscle tissue, including cardiac and hindresulted in defects in myotube viability and limb skeletal muscle ( Figure 1a) ; furthermore, JNK1 integrity in vitro, similar to a dystrophic phenotype. phosphorylation was not increased in tissues derived from
In addition, direct muscle injection of an adenoviral the MyoD Ϫ/Ϫ parent strain [12] (data not shown). In addiconstruct containing the JNK1 inhibitory protein, tion, a longer exposure of the same IP/Western reveals JIP1, dramatically attenuated the progression of evidence of the phosphorylated p46 isoform in the lysates dystrophic myofiber destruction. Taken together, with the greatest damage (similar to the pattern observed these results suggest that a JNK1-mediated signal with p54). Unlike JNK1, the phosphorylation of ERK2
cascade is a conserved feature of dystrophic muscle and p38 was not dramatically altered (Figure 1b,c) .
and contributes to the progression of the disease pathogenesis.
Similarly, Western analysis with phosphospecific JNK1 revealed a substantial increase in JNK1 isoform phosphor-tion. Finally, we examined the cellular specificity of JNK1 activation in dystrophic muscle. Immunostaining of mu- tion as a conserved feature of dystrophic muscle pathogenesis, a feature that is directly proportional to the extent of muscle damage. To determine whether elevated JNK1 activity induced pression/JNK1 activation led to a decrease in myotube integrity (Figure 2a-h ). Specifically, in C2C12 myoblast a dystrophic muscle phenotype, C2C12 skeletal muscle myoblasts and H9C2 cardiac myoblasts were stably transclones with high levels of MKK7 expression/JNK activity, the total number of myotubes decreased as the differentiafected with the JNK1-specific activating kinase, MKK7 [14, 15] . Stable transformants were then categorized by tion program proceeded. The MF-20-positive myocyte population declined from ‫%03ف‬ at 3 days postdifferentiathe level of MKK7 expression and JNK1 activity/phosphorylation. Initial assessments revealed that the growth tion to less than 8% at 5 days postdifferentiation. This is in stark contrast to wild-type and low-expressing cell lines kinetics and viability of all selected cell lines remained unchanged. Moreover, both myotube formation and difthat increase from ‫%53ف‬ to Ͼ60% MF-20-positive cells over the same time course. This temporal decline in myoferentiation were readily apparent within 3 days following serum withdrawal in all C2C12 and H9C2 clones examtube integrity was preceded by an increased vacuolization and formation of picnotic nuclei (Figure 2a,b) . Moreover, ined (Figure 2a) . Despite the neutral effect on replicating myoblasts and early myotube formation, MKK7 overexthe severity of the myotube phenotype in both C2C12 In order to assess the role of JNK1-mediated myofiber damage in vivo, we have employed the specific JNK inhibitor JIP1 (JNK interacting protein). JIP1 is a cytosolrestricted scaffolding protein that has been shown to prevent JNK1 activation via sequestration of JNK1 and its immediate upstream effector, MKK-7 [16] . JIP1 is highly specific for JNK1 and does not interact with other JNK family members or with other members of the JNK signal cascade [17] . An adenoviral construct containing JIP cDNA flanked by FLAG and GFP tags was injected into tibialis anterior muscles of 8-week-old mdx:MyoD
mice. Previous in vitro experiments using cultured sympathetic neurons showed that the adenoviral construct possessed excellent infectivity (G. Walsh, F. Miller, unpublished data). Furthermore, both JIP and GFP were detected on Western blots of lysates derived from infected cells (data not shown). Mice were sacrificed 3 weeks after viral introduction, and sectioned muscles were analyzed for the presence of GFP/JIP. In addition, GFP-positive myofiber diameters and overall health were compared to uninfected fibers within the same section and to uninjected contralateral controls. Animals injected with adenovirus encoding GFP alone served as an alternate control. In general, infected fibers appeared healthier and more robust than adjacent uninfected fibers (Figure 3a-d) or GFP controls (Figure 3f ). While uninfected myofibers often appeared vacuolated and in various stages of degeneration, the integrity of JIP adenovirus-infected fibers was maintained, exhibiting a phenotype reminiscent of that observed in wild-type tissues. In addition, the diameters of JIP-infected myofibers were between 15% and 35% larger (paired t test, p Ͻ 0.05) than uninfected myofibers (Figure 3g ). This was especially striking in areas of variable adenoviral infection, with robust JIP overexpressing
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fibers interspersed with much smaller, degenerate fibers factors have been described as key regulatory proteins for hypertrophic growth of both cardiac and skeletal muscle [18] [19] [20] . In addition, we have observed changes in gene expression coincident to JNK1 activation, which may accelerate the loss of myofiber integrity, i.e., JNK1-dependent upregulation of proapoptotic neuronal genes (See Supplementary material). Therefore, these results suggest that JNK1 activation may elicit myofiber destruction through multiple avenues.
Taken together, our results support a model in which the progression of dystrophic muscle pathogenesis is in part dependent upon JNK1 activation. The activation of JNK1 in dystrophic muscle may result from an intrinsic loss of the dystrophin protein and/or the cognate binding partners. Specifically, components of the dystrophin dystroglycan protein complex (DGC) have been shown to retain signaling molecules such as microtubule-associated serine/threonine kinase (MAST) and syntrophin-associated serine/threonine kinase (SAST) [21] . Therefore, the failure to retain these kinases in a membrane-bound DGC may provide a precipitating signal for the activation of JNK1 in a dystrophic muscle. Alternatively, JNK1 activation may originate as a secondary consequence of dystrophic myofiber destabilization. For example, disruption of the cytoskeleton (a hallmark of a dystrophic myofiber) in nonmuscle cells leads to JNK1 activation, followed by a requisite decline in cellular viability [22, 23] . Indeed, consideration of these issues raises the possibility that JNK1 activation may not be the sole arbiter of signalassociated myofiber destruction. Nevertheless, and despite the potential for signal promiscuity, the data suggest that JNK1 activation is a conserved characteristic of the dystrophic muscle phenotype.
Supplementary material
Supplementary material containing the materials and methods section and information concerning JNK1 targets and interactions as well as gene expression profiles associated with JNK1 activation is available at http://images.cellpress.com/supmat/supmatin.htm.
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